...
search icon
immx-img

Immix Biopharma Inc Share Price

IMMX
NAQ
$7.77
-$0.35
(-4.31%)
1D
Industry: Biotechnology Sector: Health Care

Immix Biopharma Inc Analyst Forecast

Immix Biopharma Inc Share Price Chart

Immix Biopharma Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$430.00M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
562.58K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.31
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.34 L
$8.25 H
$7.77

About Immix Biopharma Inc, Common Stock

Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The company' lead product is NXC-201 for relapsed/refractory AL Amyloidos. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California. more

Industry: BiotechnologySector: Health Care

Immix Biopharma Inc Stock Returns

Time FrameIMMXSectorS&P500
1-Week Return13.6%0.72%-1.31%
1-Month Return68.91%1.27%0.78%
3-Month Return82.82%3.13%3.46%
6-Month Return237.83%15.81%6.19%
1-Year Return302.59%8.89%11.68%
3-Year Return275.36%20.79%71.21%
5-Year Return111.72%35.89%74.81%

Immix Biopharma Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue--(89.52M)--[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue2.32K2.47K2.13K5.47K115.39K[{"date":"2020-12-31","value":2.01,"profit":true},{"date":"2021-12-31","value":2.14,"profit":true},{"date":"2022-12-31","value":1.85,"profit":true},{"date":"2023-12-31","value":4.74,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit(2.32K)(2.47K)(89.52M)(5.47K)(115.39K)[{"date":"2020-12-31","value":-232100,"profit":false},{"date":"2021-12-31","value":-246800,"profit":false},{"date":"2022-12-31","value":-8951913500,"profit":false},{"date":"2023-12-31","value":-546800,"profit":false},{"date":"2024-12-31","value":-11538800,"profit":false}]
Gross Margin--100.00%--[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses453.85K1.35M8.22M16.14M22.67M[{"date":"2020-12-31","value":2,"profit":true},{"date":"2021-12-31","value":5.96,"profit":true},{"date":"2022-12-31","value":36.25,"profit":true},{"date":"2023-12-31","value":71.19,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(453.85K)(1.35M)(8.22M)(16.14M)(22.67M)[{"date":"2020-12-31","value":-45385200,"profit":false},{"date":"2021-12-31","value":-135201400,"profit":false},{"date":"2022-12-31","value":-821894800,"profit":false},{"date":"2023-12-31","value":-1614111300,"profit":false},{"date":"2024-12-31","value":-2267468000,"profit":false}]
Total Non-Operating Income/Expense(778.44K)(23.21M)(994.00)915.44K2.03M[{"date":"2020-12-31","value":-38.26,"profit":false},{"date":"2021-12-31","value":-1140.49,"profit":false},{"date":"2022-12-31","value":-0.05,"profit":false},{"date":"2023-12-31","value":44.99,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(1.13M)(24.38M)(8.22M)(15.57M)(21.66M)[{"date":"2020-12-31","value":-113031600,"profit":false},{"date":"2021-12-31","value":-2437786600,"profit":false},{"date":"2022-12-31","value":-821944500,"profit":false},{"date":"2023-12-31","value":-1556910700,"profit":false},{"date":"2024-12-31","value":-2165732600,"profit":false}]
Income Taxes17.55K6.01K10.27K26.41K41.04K[{"date":"2020-12-31","value":42.76,"profit":true},{"date":"2021-12-31","value":14.65,"profit":true},{"date":"2022-12-31","value":25.02,"profit":true},{"date":"2023-12-31","value":64.37,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes(1.15M)(24.38M)(8.23M)(15.60M)(21.70M)[{"date":"2020-12-31","value":-114786300,"profit":false},{"date":"2021-12-31","value":-2438387900,"profit":false},{"date":"2022-12-31","value":-822971300,"profit":false},{"date":"2023-12-31","value":-1559552200,"profit":false},{"date":"2024-12-31","value":-2169836300,"profit":false}]
Income From Continuous Operations(1.15M)(24.38M)(8.23M)(14.24M)(21.70M)[{"date":"2020-12-31","value":-114786300,"profit":false},{"date":"2021-12-31","value":-2438387900,"profit":false},{"date":"2022-12-31","value":-822971300,"profit":false},{"date":"2023-12-31","value":-1423999300,"profit":false},{"date":"2024-12-31","value":-2169836300,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(1.15M)(24.38M)(8.23M)(15.43M)(21.61M)[{"date":"2020-12-31","value":-114786300,"profit":false},{"date":"2021-12-31","value":-2438387900,"profit":false},{"date":"2022-12-31","value":-822971300,"profit":false},{"date":"2023-12-31","value":-1542604800,"profit":false},{"date":"2024-12-31","value":-2161337600,"profit":false}]
EPS (Diluted)(0.26)(3.52)(0.59)(0.88)(0.86)[{"date":"2020-12-31","value":-25.54,"profit":false},{"date":"2021-12-31","value":-352.15,"profit":false},{"date":"2022-12-31","value":-59.02,"profit":false},{"date":"2023-12-31","value":-88,"profit":false},{"date":"2024-12-31","value":-86.44,"profit":false}]

Immix Biopharma Inc Ratios

Immix Biopharma Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

IMMX
Cash Ratio 1.47
Current Ratio 1.53

Immix Biopharma Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

IMMX
ROA (LTM) -66.48%
ROE (LTM) -182.55%

Immix Biopharma Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

IMMX
Debt Ratio Lower is generally better. Negative is bad. 0.59
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.41

Immix Biopharma Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

IMMX
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 51.96
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Immix Biopharma Inc share price today?

Immix Biopharma Inc (IMMX) share price today is $7.77

Can Indians buy Immix Biopharma Inc shares?

Yes, Indians can buy shares of Immix Biopharma Inc (IMMX) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in IMMX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Immix Biopharma Inc be purchased?

Yes, you can purchase fractional shares of Immix Biopharma Inc (IMMX) via the Vested app. You can start investing in Immix Biopharma Inc (IMMX) with a minimum investment of $1.

How to invest in Immix Biopharma Inc shares from India?

You can invest in shares of Immix Biopharma Inc (IMMX) via Vested in three simple steps:

  • Click on Sign Up or Invest in IMMX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Immix Biopharma Inc shares
What is Immix Biopharma Inc 52-week high and low stock price?

The 52-week high price of Immix Biopharma Inc (IMMX) is $8.25. The 52-week low price of Immix Biopharma Inc (IMMX) is $1.34.

What is Immix Biopharma Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Immix Biopharma Inc (IMMX) is

What is Immix Biopharma Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Immix Biopharma Inc (IMMX) is 51.96

What is Immix Biopharma Inc dividend yield?

The dividend yield of Immix Biopharma Inc (IMMX) is 0.00%

What is the Market Cap of Immix Biopharma Inc?

The market capitalization of Immix Biopharma Inc (IMMX) is $430.00M

What is Immix Biopharma Inc's stock symbol?

The stock symbol (or ticker) of Immix Biopharma Inc is IMMX

How Can Investors Use Immix Biopharma Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Immix Biopharma Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Immix Biopharma Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Immix Biopharma Inc shares for Indian investors?

When investing in Immix Biopharma Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Immix Biopharma Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Immix Biopharma Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Immix Biopharma Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Immix Biopharma Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top